BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 29071517)

  • 1. Prognostic value of change in anti-thyroglobulin antibodies after thyroidectomy in patients with papillary thyroid carcinoma.
    Ernaga-Lorea A; Hernández-Morhain MC; Anda-Apiñániz E; Pineda-Arribas JJ; Migueliz-Bermejo I; Eguílaz-Esparza N; Irigaray-Echarri A
    Clin Transl Oncol; 2018 Jun; 20(6):740-744. PubMed ID: 29071517
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in serum thyroglobulin antibody levels as a dynamic prognostic factor for early-phase recurrence of thyroglobulin antibody-positive papillary thyroid carcinoma after total thyroidectomy.
    Yamada O; Miyauchi A; Ito Y; Nakayama A; Yabuta T; Masuoka H; Fukushima M; Higashiyama T; Kihara M; Kobayashi K; Miya A
    Endocr J; 2014; 61(10):961-5. PubMed ID: 25029954
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sequential changes of serum antithyroglobulin antibody levels are a good predictor of disease activity in thyroglobulin-negative patients with papillary thyroid carcinoma.
    Hsieh CJ; Wang PW
    Thyroid; 2014 Mar; 24(3):488-93. PubMed ID: 23971786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognosis of papillary thyroid cancers with positive serum thyroglobulin antibody after total thyroidectomy.
    Kuo SF; Chao TC; Chang HY; Hsueh C; Lin CL; Chiang KC; Chuang WY; Chen YC; Lin JD
    Asian J Surg; 2017 May; 40(3):186-192. PubMed ID: 26553529
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum antithyroglobulin antibody levels are not a good predictive factor on detection of disease activity in patients with papillary thyroid carcinoma.
    Turanli S; Mersin HH
    J Cancer Res Ther; 2020; 16(3):624-629. PubMed ID: 32719278
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changing Trend of Thyroglobulin Antibodies in Patients With Differentiated Thyroid Cancer Treated With Total Thyroidectomy Without
    Matrone A; Latrofa F; Torregrossa L; Piaggi P; Gambale C; Faranda A; Ricci D; Agate L; Molinaro E; Basolo F; Vitti P; Elisei R
    Thyroid; 2018 Jul; 28(7):871-879. PubMed ID: 29860933
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic significance of changes in serum thyroglobulin antibody levels of pre- and post-total thyroidectomy in thyroglobulin antibody-positive papillary thyroid carcinoma patients.
    Tsushima Y; Miyauchi A; Ito Y; Kudo T; Masuoka H; Yabuta T; Fukushima M; Kihara M; Higashiyama T; Takamura Y; Kobayashi K; Miya A; Kikumori T; Imai T; Kiuchi T
    Endocr J; 2013; 60(7):871-6. PubMed ID: 23585494
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical Analysis of Preoperative Anti-thyroglobulin Antibody in Papillary Thyroid Cancer Between 2011 and 2015 in Beijing, China: A Retrospective Study.
    Jia X; Pang P; Wang L; Zhao L; Jiang L; Song Y; Fan X; Wang Y; Zhao S; Ba J; Yang G; Wang X; Gu W; Zang L; Pei Y; Du J; Mu Y; Lyu Z
    Front Endocrinol (Lausanne); 2020; 11():452. PubMed ID: 32760349
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detecting Recurrence Following Lobectomy for Thyroid Cancer: Role of Thyroglobulin and Thyroglobulin Antibodies.
    Ritter A; Mizrachi A; Bachar G; Vainer I; Shimon I; Hirsch D; Diker-Cohen T; Duskin-Bitan H; Robenshtok E
    J Clin Endocrinol Metab; 2020 Jun; 105(6):. PubMed ID: 32219303
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical aggressiveness and long-term outcome in patients with papillary thyroid cancer and circulating anti-thyroglobulin autoantibodies.
    Durante C; Tognini S; Montesano T; Orlandi F; Torlontano M; Puxeddu E; Attard M; Costante G; Tumino S; Meringolo D; Bruno R; Trulli F; Toteda M; Redler A; Ronga G; Filetti S; Monzani F;
    Thyroid; 2014 Jul; 24(7):1139-45. PubMed ID: 24702238
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thyroglobulin antibodies could be a potential predictive marker for papillary thyroid carcinoma.
    Vasileiadis I; Boutzios G; Charitoudis G; Koukoulioti E; Karatzas T
    Ann Surg Oncol; 2014 Aug; 21(8):2725-32. PubMed ID: 24595799
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coexistence of thyroglobulin antibodies and thyroid peroxidase antibodies correlates with elevated thyroid-stimulating hormone level and advanced tumor stage of papillary thyroid cancer.
    Wu X; Lun Y; Jiang H; Gang Q; Xin S; Duan Z; Zhang J
    Endocrine; 2014 Aug; 46(3):554-60. PubMed ID: 24338678
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Significance of Low Levels of Thyroglobulin Autoantibodies Associated with Undetectable Thyroglobulin After Thyroidectomy for Differentiated Thyroid Carcinoma.
    Latrofa F; Ricci D; Sisti E; Piaggi P; Nencetti C; Marinò M; Vitti P
    Thyroid; 2016 Jun; 26(6):798-806. PubMed ID: 27020734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of postoperative anti-thyroglobulin antibody in patients with differentiated thyroid cancer.
    Zhao Y; Mu Z; Liang D; Zhang T; Zhang X; Sun D; Sun Y; Liang J; Lin Y
    Front Endocrinol (Lausanne); 2024; 15():1354426. PubMed ID: 38721144
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigating Antithyroglobulin Antibody As a Prognostic Marker for Differentiated Thyroid Cancer: A Meta-Analysis and Systematic Review.
    Lee ZJO; Eslick GD; Edirimanne S
    Thyroid; 2020 Nov; 30(11):1601-1612. PubMed ID: 32345152
    [No Abstract]   [Full Text] [Related]  

  • 16. Thyroglobulin antibodies as a potential predictive marker of papillary thyroid carcinoma in patients with indeterminate cytology.
    Karatzas T; Vasileiadis I; Zapanti E; Charitoudis G; Karakostas E; Boutzios G
    Am J Surg; 2016 Nov; 212(5):946-952. PubMed ID: 27324384
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patients with Papillary Thyroid Carcinoma at Intermediate Risk of Recurrence According to American Thyroid Association Criteria Can Be Reclassified as Low Risk When the Postoperative Thyroglobulin Is Low.
    Rosario PW; Furtado Mde S; Mourão GF; Calsolari MR
    Thyroid; 2015 Nov; 25(11):1243-8. PubMed ID: 26359309
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thyroglobulin antibody levels do not predict disease status in papillary thyroid cancer.
    Smooke-Praw S; Ro K; Levin O; Ituarte PH; Harari A; Yeh MW
    Clin Endocrinol (Oxf); 2014 Aug; 81(2):271-5. PubMed ID: 24494778
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The value of preoperative antithyroidperoxidase antibody as a novel predictor of recurrence in papillary thyroid carcinoma.
    Song E; Oh HS; Jeon MJ; Chung KW; Hong SJ; Ryu JS; Baek JH; Lee JH; Kim WG; Kim WB; Shong YK; Kim TY
    Int J Cancer; 2019 Mar; 144(6):1414-1420. PubMed ID: 30357831
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of co-existent thyroiditis on clinical outcome in papillary thyroid carcinoma with high preoperative serum antithyroglobulin antibody: a retrospective cohort study.
    Nam HY; Lee HY; Park GC
    Clin Otolaryngol; 2016 Aug; 41(4):358-64. PubMed ID: 26283460
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.